First Half and Year to Date 2026 Financial Highlights
- Order backlog of
EUR 69 .1 million as of June 30, 2026EUR 33.0 million added to backlog sinceJune 30, 2026 , bringing total order backlog to overEUR 102.1 million as ofAugust 3, 2026
- Total revenues for the six months ended
June 30, 2026 , wereEUR 8.9 million - Operating loss for the six months ended
June 30, 2026 , wasEUR 60.5 million - Cash Balance of
EUR 309.4 million as ofJuly 2, 2026 , inclusive of listing proceeds - 2026 Financial Outlook:
- Full-Year New Order Intake Target: EUR 65 million to
EUR 75 million - Full-Year 2026 Revenue Target: EUR 42 million to EUR 47 million
- Full-Year New Order Intake Target: EUR 65 million to
First Half and Year to Date 2026 Operational Highlights
- Expansion into several new markets, including
Japan andSpain , through new customer wins and customer engagements - 17 systems in total delivered globally to customers since founding, with 26 total systems sold
- Notably, first US delivery to
US Department of Energy's Oak Ridge National Laboratory inTennessee inJune 2026 - Strong new sales momentum with a landmark deal announced with CSC, where IQM was selected to integrate a quantum computer into the
LUMI AI Factory , connected to one of the world’s leading supercomputers - Concrete use-cases exploration with
Deutsche Bahn that demonstrated a hybrid quantum-classical railway scheduling solution using real operational data on today's IQM hardware - Significant advancements in error correction, first introducing tile codes and further refining them with the "barbell codes"—a novel family of qLDPC error correction codes customized for the IQM Constellation topology, showing strong improvement in efficiency
- More than
EUR 40 million investment into industrial expansion of our proprietary fab, doubling cleanroom capacity to enable the production of up to 30 full-stack quantum computers per year - Key ecosystem partnerships and collaborations including with NVIDIA, conducting AI-driven parallel qubit calibration using the NVIDIA Ising open family of AI models, helping automate system tuning and improve system uptime
- Collaboration with HPE including integrating IQM’s superconducting quantum computers with HPE Cray HPC infrastructure for hybrid enterprise environments
- Significantly strengthened and expanded board with independent industry professionals as board members
- Expanded management team with experienced key new hires, including CTO, COO and promoting Chief Scientist
- Hosted successful inaugural Capital Markets Day in
June 2026 . Materials are available on IQM’s website - Link
"Our public debut marks a historic milestone, demonstrating how technology leadership can capture global capital to transition quantum computing from research excellence into customer-ready computing infrastructure. IQM is operating from a position of verified commercial scale with 26 full-stack quantum computers sold, 17 delivered globally, and proven integration directly alongside AI supercomputers and high-performance data centers. As we execute our product roadmap and scale toward fault-tolerant quantum computing, our focus remains squarely on operational discipline, delivering real-world value, and strengthening our proposition as the partner of choice for sovereign and enterprise compute infrastructure," said Dr.
"Our successful dual listing has fundamentally transformed our balance sheet, establishing a cash position of
This release contains a summary of IQM Quantum Computers Oyj’s financial results for the first half and second quarter of 2026. The summary focuses on group-level financial information and the Company’s outlook. Detailed financial information and notes are available in the financial report accompanying this release and on the Company's website at https://investors.iqm.tech/. We encourage investors to review the tables and notes in the full report as well.
Conference Call and Webcast
IQM will host a conference call today,
You can listen to a live audio webcast of the conference call at https://edge.media-server.com/mmc/p/k7j4grx5 or the "Events & Presentations" section of the Company's Investor Relations website at https://investors.iqm.tech/. A replay of the conference call will be available at the same locations following the conclusion of the call for one year.
About IQM Quantum Computers
IQM Quantum Computers (Nasdaq: IQMX) is a global leader in superconducting quantum computers, delivering full-stack quantum systems and cloud platform access to enterprises, research institutions, universities, high-performance computing centers, and national laboratories worldwide. IQM’s on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018 and headquartered in Finland, with major operations in Munich, IQM employs over 400 people and operates across Europe, Asia, and North America. IQM is the first publicly listed European quantum company on the Nasdaq Stock Market.
Contacts
Media contact:?
Michael Bruce
PR Manager????
press@iqm.tech
Investor contact:??
Blair Robertson
Vice President, Strategy & Corporate Development
Investor Relations Officer
investors@iqm.tech
Key Operating Metrics
In addition to the measures presented in our consolidated financial statements, we use Order Backlog and Order Intake as indicators of future revenues from existing signed orders. This approach provides management with a transparent bridge from confirmed orders to revenue, linking sales performance with revenue realization, while remaining consistent with the external definition of backlog as confirmed, not yet recognized orders. We believe these metrics provide useful information for the market to understand and evaluate our results of operations in the same manner as our management team. Order Backlog represents the value of binding customer orders that have been confirmed but not yet recognized as revenue at a point in time. We calculate Order Backlog as the point in time balance of Order Intake less recognized revenue. Order Intake represents the total monetary value of binding customer orders signed during the period, excluding pipeline or expected orders, and reflects new business secured and future revenue generation. These metrics are presented for supplemental informational purposes only, should not be considered substitutes for financial information presented in accordance with IFRS Accounting Standards, and may differ from similarly titled metrics or measures presented by other companies. In this release, we have provided our Order Backlog both as of June 30, 2026 and August 3, 2026. In future releases, we intend to only provide quarterly Order Backlog, and we do not undertake to provide post-quarter updated information.
Cautionary Language and Forward-Looking Statements
Certain statements herein that are not historical facts are forward-looking statements. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” “intends,” “outlook,” “may,” “will,” and other similar terms and phrases. Such forward-looking statements include, but are not limited to, statements regarding IQM’s strategies, future or anticipated market or competitive position, business plans and future performance, including IQM’s cash runway and outlook for the third quarter and full-year 2026. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: A) expectations, plans, benefits or outlook related to our strategies, projects, programs, product launches, growth management, licenses, intellectual property, sustainability and other ESG targets, operational key performance indicators and decisions on market exits or expansions; B) expectations, plans or benefits related to future performance of our businesses (including the expected impact, timing and duration of potential global pandemics, geopolitical conflicts and the general or regional macroeconomic conditions on our businesses, our supply chain, the timing of market changes or turning points in demand and our customers’ businesses); C) expectations and targets regarding financial performance and results of operations, including market share, prices, net sales, order backlog, order intake, income, margins, cash flows, cost savings, the timing of receivables, operating expenses, provisions, impairments, tariffs, taxes, currency exchange rates, hedging, investment funds, inflation, product cost reductions, competitiveness, value creation, and revenue generation in any specific region; D) our ability to execute, expectations, plans or benefits related to transactions, investments and changes in organizational structure and operating model, including the expansion of our manufacturing and production capacity; E) expectations related to the commercialization and market acceptance of quantum technology and the timing and progress of product development; and F) other risks and uncertainties discussed in the “Risk Factors” section of IQM’s prospectus pursuant to Rule 424(b)(3) filed with the United States Securities and Exchange Commission (the “SEC”) on June 5, 2026, IQM’s prospectus approved by the Finnish Financial Supervisory Authority (the “FIN-FSA”) on 1 July 2026, and in other filings that IQM makes from time to time with the SEC or the FIN-FSA. These statements are based on management's best assumptions and beliefs in light of the information currently available to them. IQM anticipates that subsequent events and developments may cause its views to change. IQM specifically disclaims any obligation to update the forward-looking statements in this press release except as required by law. These forward-looking statements should not be relied upon as representing IQM’s views as of any date subsequent to the date hereof.
| IQM Quantum Computers | |||
| interim condensed consolidated statement of financial position (Balance Sheet) | |||
| (in thousands, except share and per share amounts) | |||
| (unaudited) | |||
| Unaudited | |||
| in EUR thousand | |||
| Assets | |||
| Non-current assets | |||
| Intangible assets | 841 | 920 | |
| Property, plant and equipment | 61,464 | 57,931 | |
| Right-of-use assets | 10,044 | 10,949 | |
| Financial assets | 1,281 | 910 | |
| Total non-current assets | 73,630 | 70,710 | |
| Current assets | |||
| Inventories | 25,452 | 13,491 | |
| Contract assets | 8,291 | 7,286 | |
| Trade receivables | 12,200 | 15,489 | |
| Other financial assets | 5,457 | 876 | |
| Other current assets | 15,264 | 11,216 | |
| Cash and cash equivalents | 113,424 | 146,544 | |
| Total current assets | 180,089 | 194,903 | |
| Total assets | 253,719 | 265,613 | |
| in EUR thousand | |||
| Equity and liabilities | |||
| Equity | |||
| Share capital | 80 | 3 | |
| Capital reserves | 489,522 | 438,157 | |
| Retained earnings | (307,141 | (232,243 | ) |
| Other reserves | (39 | (16 | ) |
| Total equity | 182,422 | 205,900 | |
| Non-current liabilities | |||
| Loans and borrowings | 2,160 | 9,222 | |
| Lease liabilities | 11,306 | 12,185 | |
| Employee benefits | 14 | 14 | |
| Total non-current liabilities | 13,480 | 21,420 | |
| Current liabilities | |||
| Trade payables | 7,762 | 8,855 | |
| Lease liabilities | 2,341 | 2,475 | |
| Loans and borrowings | 12,810 | 8,525 | |
| Contract liabilities | 13,797 | 7,406 | |
| Employee benefits | 8,961 | 5,908 | |
| Other current liabilities | 12,145 | 5,124 | |
| Total current liabilities | 57,817 | 38,292 | |
| Total liabilities | 71,297 | 59,713 | |
| Total equity and liabilities | 253,719 | 265,613 | |
| IQM Quantum Computers | ||||||||
| interim condensed consolidated statement of loss | ||||||||
| (in thousands, except share and per share amounts) | ||||||||
| (unaudited) | ||||||||
| For the three months ended | For the six months ended | |||||||
| in EUR thousand | 2026 | 2025 | 2026 | 2025 | ||||
| Revenue from contracts with customers | 6,683 | 5,233 | 8,870 | 6,034 | ||||
| Cost of revenue | (3,623 | ) | (3,159 | ) | (5,265 | ) | (3,627 | ) |
| Gross profit | 3,060 | 2,075 | 3,604 | 2,407 | ||||
| Selling expenses | (3,805 | ) | (1,385 | ) | (7,049 | ) | (2,366 | ) |
| General and administrative expenses | (15,450 | ) | (4,380 | ) | (26,201 | ) | (6,912 | ) |
| Research and development expenses | (16,285 | ) | (11,813 | ) | (34,047 | ) | (25,650 | ) |
| Impairment losses (including reversals of impairment losses) on financial assets | (133 | ) | 4 | 20 | (4 | ) | ||
| Other operating income | 1,719 | 576 | 3,142 | 938 | ||||
| Other operating expenses | - | (46 | ) | (7 | ) | (48 | ) | |
| Operating loss | (30,895 | ) | (14,968 | ) | (60,537 | ) | (31,635 | ) |
| Finance income | 1,700 | 626 | 5,067 | 969 | ||||
| Finance costs | (7,336 | ) | (607 | ) | (19,400 | ) | (3,850 | ) |
| Loss before income tax | (36,532 | ) | (14,948 | ) | (74,871 | ) | (34,516 | ) |
| Income tax | (22 | ) | (57 | ) | (27 | ) | (59 | ) |
| Loss for the period | (36,554 | ) | (15,005 | ) | (74,897 | ) | (34,575 | ) |
| Attributable to: | ||||||||
| Equity holders of the parent | (36,554 | ) | (15,005 | ) | (74,897 | ) | (34,575 | ) |
| Loss per share (in EUR) attributable to the ordinary equity holders of the company: | ||||||||
| Basic earnings per share | (1.18 | ) | (0.49 | ) | (2.50 | ) | (1.13 | ) |
| Diluted earnings per share | (1.18 | ) | (0.49 | ) | (2.50 | ) | (1.13 | ) |
| IQM Quantum Computers | |||||
| interim condensed consolidated statement of cashflows | |||||
| (in thousands, except share and per share amounts) | |||||
| (unaudited) | |||||
| For the six months ended | |||||
| in EUR thousand | 2026 | 2025 | |||
| Loss for the period | (74,897 | ) | (34,575 | ) | |
| Adjustments for: | |||||
| Depreciation expense, amortization and impairment | 6,462 | 6,205 | |||
| Provisions | - | (40 | ) | ||
| Other adjustments for non-cash items | (98 | ) | (303 | ) | |
| Share-based payments | 8,827 | 2,334 | |||
| Finance income/cost | 14,233 | 2,790 | |||
| Income tax expense | 27 | 59 | |||
| Changes in: | |||||
| Inventories | (11,961 | ) | (2,220 | ) | |
| Contract assets | (1,004 | ) | (721 | ) | |
| Trade receivables | 3,289 | 1,717 | |||
| Other financial assets | (1,793 | ) | (2 | ) | |
| Other assets | (7,440 | ) | (3,836 | ) | |
| Trade payables | (1,093 | ) | 3,549 | ||
| Contract liabilities | 6,353 | (3,758 | ) | ||
| Employee benefits | 2,098 | 1,458 | |||
| Other liabilities | 7,021 | (115 | ) | ||
| Income taxes paid | (27 | ) | (2 | ) | |
| Cashflow from operating activities | (50,003 | ) | (27,461 | ) | |
| Proceeds from disposals of property, plant, and equipment | - | 21 | |||
| Purchases of property, plant and equipment | (7,159 | ) | (2,735 | ) | |
| Refund from purchase of property, plant and equipment | 1,000 | - | |||
| Payments for acquisition of subsidiary - net of cash | (7 | ) | - | ||
| Interest received | 977 | 628 | |||
| Cashflow from investing activities | (5,188 | ) | (2,086 | ) | |
| Proceeds from equity contributions | 39 | 155,550 | |||
| Transaction costs related to equity contributions | - | (617 | ) | ||
| Share buybacks | - | (22,421 | ) | ||
| Exercise of warrants | 20,501 | - | |||
| Proceeds from loans and borrowings | 4,225 | 3 | |||
| Repayments of loans and borrowings | (440 | ) | (5,508 | ) | |
| Repayments of lease liabilities | (1,310 | ) | (1,874 | ) | |
| Lease incentives received | - | 824 | |||
| Proceeds (payment) of other financial assets | (371 | ) | 165 | ||
| Interest paid | (637 | ) | (409 | ) | |
| Cashflow from financing activities | 22,008 | 125,713 | |||
| Net increase/(decrease) in cash and cash equivalents | (33,184 | ) | 96,166 | ||
| Cash and cash equivalents at the beginning of year | 146,544 | 17,247 | |||
| + | Effects of exchange rate changes on cash and cash equivalents | 63 | (40 | ) | |
| Cash and cash equivalents at the end of period | 113,424 | 113,373 | |||
Source: 